Pre-Clinical Research
Allogeneic Cardiospheres Safely Boost Cardiac Function and Attenuate Adverse Remodeling After Myocardial Infarction in Immunologically Mismatched Rat Strains

https://doi.org/10.1016/j.jacc.2012.10.052Get rights and content
Under an Elsevier user license
open archive

Objectives

We sought to characterize the immunologic profile of allogeneic cardiospheres, which are 3-dimensional, self-assembling, cardiac-derived microtissues, and to evaluate their safety and efficacy in repairing ischemic heart tissue.

Background

Intramyocardial injection of autologous cardiospheres ameliorates remodeling and improves global function in infarcted myocardium. It is as yet unknown whether allogeneic cardiospheres are similarly effective without eliciting deleterious immune reactions.

Methods

We expanded cardiospheres from male Wistar Kyoto rat hearts and injected them surgically in the peri-infarct zone of Wistar Kyoto (syngeneic group, n = 28) and Brown Norway female rats (allogeneic group, n = 29). Female rats from both strains (n = 37) injected with normal saline served as controls.

Results

In vitro, cardiospheres expressed a low immunogenic profile and inhibited proliferation of alloreactive T cells. In vivo, cell engraftment was similar in the syngeneic and allogeneic groups 1 week and 3 weeks after transplantation. Reductions in scar size and scar collagen content and increases in viable mass in the risk region were accompanied by improvements in left ventricular function and attenuation of left ventricle remodeling that were sustained during 6 months of follow up. Transplantation of allogeneic cardiospheres increased tissue expression of the regenerative growth factors vascular endothelial growth factor, hepatocyte growth factor, and insulin-like growth factor-1, stimulating angiogenesis. Syngeneic and allogeneic cardiospheres attenuated the inflammatory response observed histologically in the peri-infarct region.

Conclusions

Allogeneic cardiospheres increase viable myocardium, decrease scar, improve function, and attenuate adverse remodeling in the infarcted rat heart, without deleterious immunological sequelae. These observations lay the groundwork for developing cardiospheres as a novel off-the-shelf microtissue product for myocardial regeneration.

Key Words

allogeneic cardiospheres
high therapeutic potential
safe administration

Abbreviations and Acronyms

CDC
cardiosphere-derived cell
DNA
deoxyribonucleic acid
HGF
hepatocyte growth factor
IFN
interferon
IGF
insulin-like growth factor
IL
interleukin
LV
left ventricular
LVEDD
left ventricular end-diastolic diameter
LVESD
left ventricular end-systolic diameter
MHC
major histocompatibility complex
MI
myocardial infarction
PCR
polymerase chain reaction
RNA
ribonucleic acid
TNF
tumor necrosis factor
VEGF
vascular endothelial growth factor

Cited by (0)

This work was funded by the California Institute for Regenerative Medicine and the Board of Governors Heart Stem Cell Center. Dr. Eduardo Marbán holds the Mark S. Siegel Family Professorship of the Cedars-Sinai Medical Center.

Drs. Linda Marbán and Eduardo Marbán are founders and equity holders in Capricor, Inc. Dr. Linda Marbán receives salary from Capricor, Inc. Drs. Malliaras and Terrovitis are consultants of Capricor, Inc. All other authors have reported they have no relationships relevant to the contents of this paper to disclose.